JF
CNTA

Jump Financial’s Centessa Pharmaceuticals CNTA Stock Holding History

Jump Financial’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,700
Closed -$430K – 1635
2024
Q4 		$430K Sell
25,700
-23,411
-48% -$388K 0.01% 1150
2024
Q3 		$785K Buy
49,111
+24,735
+101% +$303K 0.02% 905
2024
Q2 		$220K Sell
24,376
-8,497
-26% -$80.6K ﹤0.01% 1520
2024
Q1 		$371K Buy
32,873
+18,573
+130% +$176K 0.01% 1336
2023
Q4 		$114K Buy
+14,300
New +$95.9K ﹤0.01% 1649

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jump Financial's CNTA Position: Q1 2025 in Review

Jump Financial sold out of Centessa Pharmaceuticals (CNTA) in Q1 2025, closing a stake of 25,700 shares — an estimated $430K sold.

Jump Financial first reported a position in CNTA in Q4 2023 and held it in 5 quarters. The position peaked at $785K in Q3 2024. 129 funds tracked by Wall St. Rank hold CNTA as of Q1 2025.

  • Jump Financial reported no remaining Centessa Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Jump Financial sold 25,700 Centessa Pharmaceuticals shares in Q1 2025, an estimated $430K.
  • Jump Financial first reported a position in Centessa Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Jump Financial's Centessa Pharmaceuticals position peaked at $785K in Q3 2024.
  • 129 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2025.

Based on Jump Financial's 13F filing for Q1 2025, filed 14 May 2025.